• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: Aspect Imaging wins FDA 510(k) for Embrace neonatal MRI

UPDATE: Aspect Imaging wins FDA 510(k) for Embrace neonatal MRI

July 27, 2017 By Fink Densford

Aspect Imaging

Updated to include comment from Aspect Imaging

The FDA today granted 510(k) clearance to Aspect Imaging‘s Embrace Neonatal magnetic resonance imaging device, which it touted as the 1st MRI device specifically designed for neonatal brain and head imaging.

The Embrace Neonatal MRI system is designed specifically for imaging neonatal heads, and can be used on nenonates with a head circumference of up to 38 cm and a weight between 1 and 4.5 kg, according to an FDA release. The system includes a temperature-controlled incubator which can be placed directly into the MRI system to reduce movement.

“The vision of Aspect Imaging is to bring clinical diagnostic information to where it is needed the most, and to help neonatologists with their diagnostic decisions. It is now possible to routinely scan premature babies in the NICU, almost immediately after birth, helping to increase the quality of life and improve care for newborns, by assisting in the early detection of health issues, enabling at-risk babies to grow into healthy children,” CEO Uri Rapoport said in a press release

The system allows for urgent access to the neonates if necessary, with the baby typically able to be removed from the system in less than 30 seconds, according to a press release.

Aspect Imaging’s Embrace neonatal MRI system is designed to be placed inside an NICU environment and does not require that devices or implants in close proximity be “MR Conditional” or “MR Safe” as the system is fully enclosed and shielded, according to a press release.

“Although we can use traditional MRI scanners to image neonates, taking babies outside of the neonatal intensive care unit to MRI suites presents great challenges. Having a system in the neonatal intensive care enables safer imaging for this vulnerable patient population,” FDA CDRH pediatrics & special populations chief medical officer Dr. Vasum Peiris said in a press release.

In April, Aspect Imaging raised $30 million to support the development of its Embrace Neonatal MRI system and a newer, stroke-dedicated MRI system.

Filed Under: 510(k), Food & Drug Administration (FDA), Imaging, Regulatory/Compliance Tagged With: Aspect Imaging

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy